Light-chain Amyloidosis
📧 Sign up to get email alerts when something new happens for Light-chain Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-10-18Clinical Trial Update: Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis [Phase 2]
A Phase 2 trial evaluating isatuximab with bendamustine for systemic light-chain (AL) amyloidosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-21Clinical Trial Update: High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease [Phase 2]
A Phase 2 clinical trial evaluating high-cutoff hemodialysis in patients with advanced cardiac AL amyloidosis and end-stage renal disease ha…